Efficiency and safety of lipid-lowering therapy for chronic kidney disease

Abstract

The paper considers the problem of lipid-lowering therapy for chronic kidney disease, by using different groups of drugs, the expediency, efficiency, and safety of the therapy at different disease stages, including end-stage renal failure, and replacement treatments.

Keywords

• chronic kidney disease
• lipid-lowering treatment